GH RESEARCH PLC news, videos and press releases
For more news please use our advanced search feature.
GH RESEARCH PLC - More news...
GH RESEARCH PLC - More news...
- GH Research Reports Full Year 2023 Financial Results and Provides Business Updates
- GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression
- GH Research Reports Third Quarter Financial Results and Provides Business Updates
- GH Research Provides Updates and Guidance on its Clinical Development Program for GH001 in Treatment-Resistant Depression
- GH Research Reports Second Quarter 2023 Financial Results and Provides Business Updates
- GH Research Reports First Quarter 2023 Financial Results and Provides Business Highlights
- GH Research Reports Full Year 2022 Financial Results and Provides Business Updates
- GH Research Provides Business Updates and Highlights Key Upcoming Milestones
- GH Research Reports Third Quarter 2022 Financial Results and Provides Business Updates
- GH Research Reports Second Quarter 2022 Financial Results and Provides Business Updates
- GH Research Reports First Quarter 2022 Financial Results and Provides Business Updates
- GH Research Reports Full Year 2021 Financial Results and Provides Business Updates
- GH Research Reports Third Quarter 2021 Financial Results and Provides Business Updates
- GH Research Announces Successful Outcome of the Phase 2 part of its Phase 1/2 Clinical Trial of GH001 in Treatment-Resistant Depression
- GH Research PLC Provides Business Updates and Reports Second Quarter 2021 Financial Results
